$BUDA

BUDA JUICE, INC.

2
0
0

No SEC Form 4 filings for $BUDA in the last 30 days.

See all $BUDA insider activity →
Med

Roth launches Buda Juice coverage with $12 target on retail expansion potential

Buda Juice Inc (NYSE:BUDA) shares rose 5% after Roth/MKM initiated coverage with a Buy rating and $12.00 price target, citing confidence in its retail expansion. The firm sees potential in the company's ability to replicate its Texas model nationwide. Investors will watch store rollouts and distribution metrics for execution.

Buda Juice (BUDA) 2025 report: profits, key customer risk and expansion

Buda Juice, Inc. (BUDA) has filed its 2025 annual report, revealing net profits of $3.53 million for 2025 and $3.57 million for 2024, despite a decrease in gross profit margin due to higher produce costs. The company, which specializes in UltraFresh™ cold-crafted citrus juices, highlights a significant customer concentration risk, with one customer accounting for 97% of its 2025 net sales. Buda Juice plans a strategic three-hub expansion into South Carolina and Arizona/Nevada to mitigate this risk and serve a broader U.S. consumer base.

BUDA sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 2 news stories mentioning BUDA (BUDA JUICE, INC.). Coverage has skewed bullish: 2 bullish, 0 neutral, and 0 bearish.

Recent BUDA coverage spans market movers and financial news.

What's driving BUDA

  • Analyst initiation and buy rating with a target above current price suggest further upside.

    investing.com · Sep 28, 2026

  • Buda Juice's 2025 financial results show stable profits but highlight significant customer concentration risk, with plans for geographic expansion to mitigate this. The company's prospects are cautiously optimistic, with potential for growth balanced against operational risks.

    Stock Titan · Mar 27, 2026

AlphAI scores every news story that mentions BUDA with an AI model for sentiment and relevance, and aggregates insider trades from BUDA JUICE, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $BUDA

Score
$BUDAMed

Buda Juice (BUDA) 2025 report: profits, key customer risk and expansion

Buda Juice, Inc. (BUDA) has filed its 2025 annual report, revealing net profits of $3.53 million for 2025 and $3.57 million for 2024, despite a decrease in gross profit margin due to higher produce costs. The company, which specializes in UltraFresh™ cold-crafted citrus juices, highlights a significant customer concentration risk, with one customer accounting for 97% of its 2025 net sales. Buda Juice plans a strategic three-hub expansion into South Carolina and Arizona/Nevada to mitigate this risk and serve a broader U.S. consumer base.

Related tickers